Request for Covid-19 Impact Assessment of this Report
The United States Herpes Simplex Virus Infection Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Herpes Simplex Virus Infection Treatment market, reaching US$ million by the year 2028. As for the Europe Herpes Simplex Virus Infection Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Herpes Simplex Virus Infection Treatment players cover F. Hoffmann-La Roche Ltd, Sanofi, Teva Pharmaceuticals Inc, and Merck & Co., Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Herpes Simplex Virus Infection Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
By Type
Herpes Simplex Virus-1 (HSV-1) Infection
Herpes Simplex Virus-2 (HSV-2) Infection
HSV1 & HSV2 Co-infection
By Route of Administration
Oral
Parenteral
By Drug Molecule
Small Molecule
Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
F. Hoffmann-La Roche Ltd
Sanofi
Teva Pharmaceuticals Inc
Merck & Co., Inc
Apotex Inc
Viatris
Epi Health LLC
Zydus Pharmaceuticals
GlaxoSmithKline LLC
Carlsbad Tech
Avet Pharmaceuticals Inc
Glenmark Pharmaceuticals
Fresenius Kabi
Agenus, Inc
Maruho Co. Ltd
AiCuris Anti-infective Cures GmbH
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Herpes Simplex Virus Infection Treatment Market Size 2017-2028
2.1.2 Herpes Simplex Virus Infection Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Herpes Simplex Virus Infection Treatment Segment by Type
2.2.1 Herpes Simplex Virus-1 (HSV-1) Infection
2.2.2 Herpes Simplex Virus-2 (HSV-2) Infection
2.2.3 HSV1 & HSV2 Co-infection
2.3 Herpes Simplex Virus Infection Treatment Market Size by Type
2.3.1 Herpes Simplex Virus Infection Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Type (2017-2022)
2.4 Herpes Simplex Virus Infection Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Herpes Simplex Virus Infection Treatment Market Size by Application
2.5.1 Herpes Simplex Virus Infection Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Application (2017-2022)
3 Herpes Simplex Virus Infection Treatment Market Size by Player
3.1 Herpes Simplex Virus Infection Treatment Market Size Market Share by Players
3.1.1 Global Herpes Simplex Virus Infection Treatment Revenue by Players (2020-2022)
3.1.2 Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Herpes Simplex Virus Infection Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Herpes Simplex Virus Infection Treatment by Regions
4.1 Herpes Simplex Virus Infection Treatment Market Size by Regions (2017-2022)
4.2 Americas Herpes Simplex Virus Infection Treatment Market Size Growth (2017-2022)
4.3 APAC Herpes Simplex Virus Infection Treatment Market Size Growth (2017-2022)
4.4 Europe Herpes Simplex Virus Infection Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Herpes Simplex Virus Infection Treatment Market Size by Country (2017-2022)
5.2 Americas Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022)
5.3 Americas Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Herpes Simplex Virus Infection Treatment Market Size by Region (2017-2022)
6.2 APAC Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022)
6.3 APAC Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Herpes Simplex Virus Infection Treatment by Country (2017-2022)
7.2 Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022)
7.3 Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Herpes Simplex Virus Infection Treatment by Region (2017-2022)
8.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Herpes Simplex Virus Infection Treatment Market Forecast
10.1 Global Herpes Simplex Virus Infection Treatment Forecast by Regions (2023-2028)
10.1.1 Global Herpes Simplex Virus Infection Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Herpes Simplex Virus Infection Treatment Forecast
10.1.3 APAC Herpes Simplex Virus Infection Treatment Forecast
10.1.4 Europe Herpes Simplex Virus Infection Treatment Forecast
10.1.5 Middle East & Africa Herpes Simplex Virus Infection Treatment Forecast
10.2 Americas Herpes Simplex Virus Infection Treatment Forecast by Country (2023-2028)
10.2.1 United States Herpes Simplex Virus Infection Treatment Market Forecast
10.2.2 Canada Herpes Simplex Virus Infection Treatment Market Forecast
10.2.3 Mexico Herpes Simplex Virus Infection Treatment Market Forecast
10.2.4 Brazil Herpes Simplex Virus Infection Treatment Market Forecast
10.3 APAC Herpes Simplex Virus Infection Treatment Forecast by Region (2023-2028)
10.3.1 China Herpes Simplex Virus Infection Treatment Market Forecast
10.3.2 Japan Herpes Simplex Virus Infection Treatment Market Forecast
10.3.3 Korea Herpes Simplex Virus Infection Treatment Market Forecast
10.3.4 Southeast Asia Herpes Simplex Virus Infection Treatment Market Forecast
10.3.5 India Herpes Simplex Virus Infection Treatment Market Forecast
10.3.6 Australia Herpes Simplex Virus Infection Treatment Market Forecast
10.4 Europe Herpes Simplex Virus Infection Treatment Forecast by Country (2023-2028)
10.4.1 Germany Herpes Simplex Virus Infection Treatment Market Forecast
10.4.2 France Herpes Simplex Virus Infection Treatment Market Forecast
10.4.3 UK Herpes Simplex Virus Infection Treatment Market Forecast
10.4.4 Italy Herpes Simplex Virus Infection Treatment Market Forecast
10.4.5 Russia Herpes Simplex Virus Infection Treatment Market Forecast
10.5 Middle East & Africa Herpes Simplex Virus Infection Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Herpes Simplex Virus Infection Treatment Market Forecast
10.5.2 South Africa Herpes Simplex Virus Infection Treatment Market Forecast
10.5.3 Israel Herpes Simplex Virus Infection Treatment Market Forecast
10.5.4 Turkey Herpes Simplex Virus Infection Treatment Market Forecast
10.5.5 GCC Countries Herpes Simplex Virus Infection Treatment Market Forecast
10.6 Global Herpes Simplex Virus Infection Treatment Forecast by Type (2023-2028)
10.7 Global Herpes Simplex Virus Infection Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Information
11.1.2 F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Product Offered
11.1.3 F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.1.5 F. Hoffmann-La Roche Ltd Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Herpes Simplex Virus Infection Treatment Product Offered
11.2.3 Sanofi Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Teva Pharmaceuticals Inc
11.3.1 Teva Pharmaceuticals Inc Company Information
11.3.2 Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Product Offered
11.3.3 Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Teva Pharmaceuticals Inc Main Business Overview
11.3.5 Teva Pharmaceuticals Inc Latest Developments
11.4 Merck & Co., Inc
11.4.1 Merck & Co., Inc Company Information
11.4.2 Merck & Co., Inc Herpes Simplex Virus Infection Treatment Product Offered
11.4.3 Merck & Co., Inc Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Merck & Co., Inc Main Business Overview
11.4.5 Merck & Co., Inc Latest Developments
11.5 Apotex Inc
11.5.1 Apotex Inc Company Information
11.5.2 Apotex Inc Herpes Simplex Virus Infection Treatment Product Offered
11.5.3 Apotex Inc Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Apotex Inc Main Business Overview
11.5.5 Apotex Inc Latest Developments
11.6 Viatris
11.6.1 Viatris Company Information
11.6.2 Viatris Herpes Simplex Virus Infection Treatment Product Offered
11.6.3 Viatris Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Viatris Main Business Overview
11.6.5 Viatris Latest Developments
11.7 Epi Health LLC
11.7.1 Epi Health LLC Company Information
11.7.2 Epi Health LLC Herpes Simplex Virus Infection Treatment Product Offered
11.7.3 Epi Health LLC Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Epi Health LLC Main Business Overview
11.7.5 Epi Health LLC Latest Developments
11.8 Zydus Pharmaceuticals
11.8.1 Zydus Pharmaceuticals Company Information
11.8.2 Zydus Pharmaceuticals Herpes Simplex Virus Infection Treatment Product Offered
11.8.3 Zydus Pharmaceuticals Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Zydus Pharmaceuticals Main Business Overview
11.8.5 Zydus Pharmaceuticals Latest Developments
11.9 GlaxoSmithKline LLC
11.9.1 GlaxoSmithKline LLC Company Information
11.9.2 GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Product Offered
11.9.3 GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 GlaxoSmithKline LLC Main Business Overview
11.9.5 GlaxoSmithKline LLC Latest Developments
11.10 Carlsbad Tech
11.10.1 Carlsbad Tech Company Information
11.10.2 Carlsbad Tech Herpes Simplex Virus Infection Treatment Product Offered
11.10.3 Carlsbad Tech Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Carlsbad Tech Main Business Overview
11.10.5 Carlsbad Tech Latest Developments
11.11 Avet Pharmaceuticals Inc
11.11.1 Avet Pharmaceuticals Inc Company Information
11.11.2 Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Product Offered
11.11.3 Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Avet Pharmaceuticals Inc Main Business Overview
11.11.5 Avet Pharmaceuticals Inc Latest Developments
11.12 Glenmark Pharmaceuticals
11.12.1 Glenmark Pharmaceuticals Company Information
11.12.2 Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Product Offered
11.12.3 Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Glenmark Pharmaceuticals Main Business Overview
11.12.5 Glenmark Pharmaceuticals Latest Developments
11.13 Fresenius Kabi
11.13.1 Fresenius Kabi Company Information
11.13.2 Fresenius Kabi Herpes Simplex Virus Infection Treatment Product Offered
11.13.3 Fresenius Kabi Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Fresenius Kabi Main Business Overview
11.13.5 Fresenius Kabi Latest Developments
11.14 Agenus, Inc
11.14.1 Agenus, Inc Company Information
11.14.2 Agenus, Inc Herpes Simplex Virus Infection Treatment Product Offered
11.14.3 Agenus, Inc Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Agenus, Inc Main Business Overview
11.14.5 Agenus, Inc Latest Developments
11.15 Maruho Co. Ltd
11.15.1 Maruho Co. Ltd Company Information
11.15.2 Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Product Offered
11.15.3 Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Maruho Co. Ltd Main Business Overview
11.15.5 Maruho Co. Ltd Latest Developments
11.16 AiCuris Anti-infective Cures GmbH
11.16.1 AiCuris Anti-infective Cures GmbH Company Information
11.16.2 AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Product Offered
11.16.3 AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 AiCuris Anti-infective Cures GmbH Main Business Overview
11.16.5 AiCuris Anti-infective Cures GmbH Latest Developments
12 Research Findings and Conclusion
Table 1. Herpes Simplex Virus Infection Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Herpes Simplex Virus-1 (HSV-1) Infection
Table 3. Major Players of Herpes Simplex Virus-2 (HSV-2) Infection
Table 4. Major Players of HSV1 & HSV2 Co-infection
Table 5. Herpes Simplex Virus Infection Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Type (2017-2022)
Table 8. Herpes Simplex Virus Infection Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Application (2017-2022)
Table 11. Global Herpes Simplex Virus Infection Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Player (2020-2022)
Table 13. Herpes Simplex Virus Infection Treatment Key Players Head office and Products Offered
Table 14. Herpes Simplex Virus Infection Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Herpes Simplex Virus Infection Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Regions (2017-2022)
Table 19. Americas Herpes Simplex Virus Infection Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Herpes Simplex Virus Infection Treatment Market Size Market Share by Country (2017-2022)
Table 21. Americas Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Herpes Simplex Virus Infection Treatment Market Size Market Share by Type (2017-2022)
Table 23. Americas Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Herpes Simplex Virus Infection Treatment Market Size Market Share by Application (2017-2022)
Table 25. APAC Herpes Simplex Virus Infection Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Herpes Simplex Virus Infection Treatment Market Size Market Share by Region (2017-2022)
Table 27. APAC Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Herpes Simplex Virus Infection Treatment Market Size Market Share by Type (2017-2022)
Table 29. APAC Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Herpes Simplex Virus Infection Treatment Market Size Market Share by Application (2017-2022)
Table 31. Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Herpes Simplex Virus Infection Treatment Market Size Market Share by Country (2017-2022)
Table 33. Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Herpes Simplex Virus Infection Treatment Market Size Market Share by Type (2017-2022)
Table 35. Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Herpes Simplex Virus Infection Treatment Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Herpes Simplex Virus Infection Treatment
Table 44. Key Market Challenges & Risks of Herpes Simplex Virus Infection Treatment
Table 45. Key Industry Trends of Herpes Simplex Virus Infection Treatment
Table 46. Global Herpes Simplex Virus Infection Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Herpes Simplex Virus Infection Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Herpes Simplex Virus Infection Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Herpes Simplex Virus Infection Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Herpes Simplex Virus Infection Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Herpes Simplex Virus Infection Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 52. F. Hoffmann-La Roche Ltd Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 53. F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Product Offered
Table 54. F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. F. Hoffmann-La Roche Ltd Main Business
Table 56. F. Hoffmann-La Roche Ltd Latest Developments
Table 57. Sanofi Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 58. Sanofi Herpes Simplex Virus Infection Treatment Product Offered
Table 59. Sanofi Main Business
Table 60. Sanofi Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Sanofi Latest Developments
Table 62. Teva Pharmaceuticals Inc Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 63. Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Product Offered
Table 64. Teva Pharmaceuticals Inc Main Business
Table 65. Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Teva Pharmaceuticals Inc Latest Developments
Table 67. Merck & Co., Inc Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 68. Merck & Co., Inc Herpes Simplex Virus Infection Treatment Product Offered
Table 69. Merck & Co., Inc Main Business
Table 70. Merck & Co., Inc Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Merck & Co., Inc Latest Developments
Table 72. Apotex Inc Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 73. Apotex Inc Herpes Simplex Virus Infection Treatment Product Offered
Table 74. Apotex Inc Main Business
Table 75. Apotex Inc Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Apotex Inc Latest Developments
Table 77. Viatris Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 78. Viatris Herpes Simplex Virus Infection Treatment Product Offered
Table 79. Viatris Main Business
Table 80. Viatris Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Viatris Latest Developments
Table 82. Epi Health LLC Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 83. Epi Health LLC Herpes Simplex Virus Infection Treatment Product Offered
Table 84. Epi Health LLC Main Business
Table 85. Epi Health LLC Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Epi Health LLC Latest Developments
Table 87. Zydus Pharmaceuticals Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 88. Zydus Pharmaceuticals Herpes Simplex Virus Infection Treatment Product Offered
Table 89. Zydus Pharmaceuticals Main Business
Table 90. Zydus Pharmaceuticals Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Zydus Pharmaceuticals Latest Developments
Table 92. GlaxoSmithKline LLC Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 93. GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Product Offered
Table 94. GlaxoSmithKline LLC Main Business
Table 95. GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. GlaxoSmithKline LLC Latest Developments
Table 97. Carlsbad Tech Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 98. Carlsbad Tech Herpes Simplex Virus Infection Treatment Product Offered
Table 99. Carlsbad Tech Main Business
Table 100. Carlsbad Tech Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Carlsbad Tech Latest Developments
Table 102. Avet Pharmaceuticals Inc Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 103. Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Product Offered
Table 104. Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Avet Pharmaceuticals Inc Main Business
Table 106. Avet Pharmaceuticals Inc Latest Developments
Table 107. Glenmark Pharmaceuticals Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 108. Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Product Offered
Table 109. Glenmark Pharmaceuticals Main Business
Table 110. Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Glenmark Pharmaceuticals Latest Developments
Table 112. Fresenius Kabi Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 113. Fresenius Kabi Herpes Simplex Virus Infection Treatment Product Offered
Table 114. Fresenius Kabi Main Business
Table 115. Fresenius Kabi Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Fresenius Kabi Latest Developments
Table 117. Agenus, Inc Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 118. Agenus, Inc Herpes Simplex Virus Infection Treatment Product Offered
Table 119. Agenus, Inc Main Business
Table 120. Agenus, Inc Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Agenus, Inc Latest Developments
Table 122. Maruho Co. Ltd Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 123. Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Product Offered
Table 124. Maruho Co. Ltd Main Business
Table 125. Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Maruho Co. Ltd Latest Developments
Table 127. AiCuris Anti-infective Cures GmbH Details, Company Type, Herpes Simplex Virus Infection Treatment Area Served and Its Competitors
Table 128. AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Product Offered
Table 129. AiCuris Anti-infective Cures GmbH Main Business
Table 130. AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. AiCuris Anti-infective Cures GmbH Latest Developments
List of Figures
Figure 1. Herpes Simplex Virus Infection Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Herpes Simplex Virus Infection Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Type in 2021
Figure 7. Herpes Simplex Virus Infection Treatment in Hospital Pharmacies
Figure 8. Global Herpes Simplex Virus Infection Treatment Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. Herpes Simplex Virus Infection Treatment in Retail Pharmacies
Figure 10. Global Herpes Simplex Virus Infection Treatment Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 11. Herpes Simplex Virus Infection Treatment in Online Pharmacies
Figure 12. Global Herpes Simplex Virus Infection Treatment Market: Online Pharmacies (2017-2022) & ($ Millions)
Figure 13. Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Application in 2021
Figure 14. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Player in 2021
Figure 15. Global Herpes Simplex Virus Infection Treatment Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Herpes Simplex Virus Infection Treatment Market Size 2017-2022 ($ Millions)
Figure 17. APAC Herpes Simplex Virus Infection Treatment Market Size 2017-2022 ($ Millions)
Figure 18. Europe Herpes Simplex Virus Infection Treatment Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Americas Herpes Simplex Virus Infection Treatment Value Market Share by Country in 2021
Figure 21. Americas Herpes Simplex Virus Infection Treatment Consumption Market Share by Type in 2021
Figure 22. Americas Herpes Simplex Virus Infection Treatment Market Size Market Share by Application in 2021
Figure 23. United States Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Herpes Simplex Virus Infection Treatment Market Size Market Share by Region in 2021
Figure 28. APAC Herpes Simplex Virus Infection Treatment Market Size Market Share by Application in 2021
Figure 29. China Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Herpes Simplex Virus Infection Treatment Market Size Market Share by Country in 2021
Figure 36. Europe Herpes Simplex Virus Infection Treatment Market Size Market Share by Type in 2021
Figure 37. Europe Herpes Simplex Virus Infection Treatment Market Size Market Share by Application in 2021
Figure 38. Germany Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Market Share by Application in 2021
Figure 46. Egypt Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Herpes Simplex Virus Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 52. APAC Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 53. Europe Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 55. United States Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Canada Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 59. China Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Japan Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Korea Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 63. India Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Australia Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Germany Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 66. France Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 67. UK Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Italy Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Russia Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Spain Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Israel Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Herpes Simplex Virus Infection Treatment Market Size 2023-2028 ($ Millions)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...